For years, the cardiovascular community has debated the “J-curve” phenomenon—the idea that while lowering high blood pressure is beneficial, dropping it too low might actually increase mortality and cardiovascular risks. However, a massive new 10-year follow-up study out of South Korea suggests that when it comes to diastolic blood pressure (DBP) in young adults, lower might simply be better.
The study, which analyzed data from over 5.6 million individuals, found a strictly linear relationship between lower DBP and reduced clinical events, with absolutely no evidence of a J-curve turnaround.
The Scale of the Study
Researchers leveraged the Korean National Insurance database to track 5,653,590 adults aged 20 to 39 between 2007 and 2010. The cohort was divided into two primary categories:
- Normotensive individuals: 5,244,439 participants
- Hypertensive individuals: 409,151 participants (defined as SBP/DBP $\ge$ 140/90 mmHg or taking antihypertensive medication)
Participants were stratified into seven distinct groups based on their DBP, ranging from under 60 mmHg to 110 mmHg or higher, and followed for a decade to track a primary composite endpoint of myocardial infarction (MI), heart failure (HF), stroke, and total mortality.
The Results: A Clear Linear Trend
The 10-year data revealed a stark, stepwise decrease in cardiovascular events and deaths as diastolic blood pressure dropped. When compared to the highest risk group ($\ge$ 110 mmHg), the hazard ratios (HR) fell progressively with lower blood pressure.
Primary Composite Endpoint Outcomes (Per 10,000 People)
| DBP Group | Events per 10,000 | Hazard Ratio (HR)* |
|---|---|---|
| $\ge$ 110 mmHg | 1,044 | 1.0 (Reference) |
| 100–109 mmHg | 581 | 0.60 |
| 90–99 mmHg | 378 | 0.44 |
| 80–89 mmHg | 227 | 0.33 |
| 70–79 mmHg | 153 | 0.27 |
| 60–69 mmHg | 122 | 0.25 |
| < 60 mmHg | 108 | 0.24 |
*All p-values < 0.001
Consistent Across Both Healthy and Hypertensive Cohorts
Crucially, this linear benefit was not exclusive to those trying to control severe hypertension. The exact same trend was observed when looking strictly at the healthy, normotensive population.
Among normotensive young adults, using the 80–89 DBP range as a reference point, the risk dropped steadily as DBP lowered:
- 70–79 mmHg: HR of 0.85
- 60–69 mmHg: HR of 0.78
- < 60 mmHg: HR of 0.75
Whether a participant was naturally low or lowered via medication, a DBP of less than 60 mmHg consistently yielded the lowest rate of adverse clinical events (just 108 events per 10,000).
Longevity Implications: Rethinking the “J-Phenomenon”
“Lower DBP was associated with better clinical outcomes in young adults irrespective of hypertension in 10-year follow-up,” the researchers concluded. “This relationship was linear and no J-phenomenon was detected.”
For the longevity and preventative medicine communities, this study provides powerful evidence for early and aggressive blood pressure optimization. While older populations with stiffened arteries are often protected from ultra-low DBPs to maintain organ perfusion, this data suggests that in young, healthy vasculature, a low DBP is highly protective.
Rather than viewing a DBP below 60 mmHg as a cause for concern in young adults, the authors suggest it should be embraced as both a stellar prognostic marker for long-term health and a legitimate target for blood pressure management.
Diastolic blood pressure and long-term clinical outcome in young age: 10-year follow-up of 5,653,590 from Korean nation-wide data
@adssx @CronosTempi
.